• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Histopathologic, immunophenotypic, and genotypic analysis of Ki-1 anaplastic large cell lymphomas that express histiocyte-associated antigens.

作者信息

Carbone A, Gloghini A, De Re V, Tamaro P, Boiocchi M, Volpe R

机构信息

Division of Pathology, Centro di Riferimento Oncologico, Aviano, Italy.

出版信息

Cancer. 1990 Dec 15;66(12):2547-56. doi: 10.1002/1097-0142(19901215)66:12<2547::aid-cncr2820661217>3.0.co;2-6.

DOI:10.1002/1097-0142(19901215)66:12<2547::aid-cncr2820661217>3.0.co;2-6
PMID:2174301
Abstract

CD30/Ki-1 antigen expression in 243 cases of malignant lymphomas was examined using Ber-H2 monoclonal antibody. Among them 20 cases were categorized as Ki-1 anaplastic large cell lymphoma. In two of these cases histiocyte-associated markers were also expressed. In these cases histopathologic and extensive in situ immunophenotypic analyses were used with genotypic studies in the determination of cell lineage. A sinusoid histologic pattern of involvement with partial lymph node infiltration by pleomorphic neoplastic cells was noticed in the nodes from both patients. Solid areas of node replacement resembling metastatic carcinoma were seen in Patient 1. Immunohistologically, tumor cells of both cases were positive for CD30, CD25, CD71, LN3 (HLA-DR), EMA, CD45, CD74, vimentin, alpha-1-antichymotrypsin, and CD68. Patient 1 was also CD45RO+, CD43+, whereas Patient 2 was positive for alpha-1-antitrypsin and CD4 tumor cells. Genotypic studies revealed that TCR beta and TCR gamma chain genes were clonally rearranged in Patient 1, whereas no rearrangements were detected in Patient 2. This study supports the view that some Ki-1 anaplastic large cell lymphomas may express multiple histiocyte-associated antigens and confirms that this group of neoplasms have immunophenotypic heterogeneity. The results of genotypic analyses used with immunophenotyping does not exclude that the tumor cells in these cases may be of true histiocytic origin despite the Ki-1-positive phenotype.

摘要

相似文献

1
Histopathologic, immunophenotypic, and genotypic analysis of Ki-1 anaplastic large cell lymphomas that express histiocyte-associated antigens.
Cancer. 1990 Dec 15;66(12):2547-56. doi: 10.1002/1097-0142(19901215)66:12<2547::aid-cncr2820661217>3.0.co;2-6.
2
KP1 (CD68)-positive large cell lymphomas: a histopathologic and immunophenotypic characterization of 12 cases.KP1(CD68)阳性大细胞淋巴瘤:12例病例的组织病理学和免疫表型特征
Hum Pathol. 1993 Aug;24(8):886-96. doi: 10.1016/0046-8177(93)90139-8.
3
Comparison of anaplastic large cell Ki-1 lymphomas and microvillous lymphomas in their immunologic and ultrastructural features.间变性大细胞Ki-1淋巴瘤与微绒毛淋巴瘤的免疫和超微结构特征比较。
Am J Surg Pathol. 1990 Nov;14(11):1047-60. doi: 10.1097/00000478-199011000-00006.
4
Ki-1-positive large cell lymphomas, a heterogenous group of neoplasms. Morphologic, immunophenotypic, genotypic, and clinical features of 24 cases.Ki-1阳性大细胞淋巴瘤,一组异质性肿瘤。24例病例的形态学、免疫表型、基因型及临床特征
Cancer. 1991 Jul 15;68(2):362-73. doi: 10.1002/1097-0142(19910715)68:2<362::aid-cncr2820680226>3.0.co;2-c.
5
Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis.间变性大细胞淋巴瘤上皮膜抗原(EMA)、Ki-1和白细胞介素-2受体的共表达。在所谓恶性组织细胞增多症中的诊断价值。
Am J Pathol. 1988 Jan;130(1):59-70.
6
Tumours classified as "malignant histiocytosis" in children are T-cell neoplasms.儿童中被归类为“恶性组织细胞增多症”的肿瘤是T细胞肿瘤。
APMIS. 1992 Jun;100(6):558-66. doi: 10.1111/j.1699-0463.1992.tb00911.x.
7
True histiocytic lymphoma: histopathologic, immunophenotypic and genotypic analysis.真性组织细胞淋巴瘤:组织病理学、免疫表型及基因分型分析
Br J Haematol. 1989 Oct;73(2):187-98. doi: 10.1111/j.1365-2141.1989.tb00251.x.
8
Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1 + with a high content of reactive histiocytes).淋巴组织细胞性T细胞淋巴瘤(间变性大细胞淋巴瘤,CD30+/Ki-1+,伴有高含量反应性组织细胞)
Histopathology. 1990 Apr;16(4):383-91. doi: 10.1111/j.1365-2559.1990.tb01143.x.
9
CD30-positive, anaplastic large-cell lymphomas that express CD15 but lack CD45. A possible diagnostic pitfall.表达CD15但缺乏CD45的CD30阳性间变性大细胞淋巴瘤。一个可能的诊断陷阱。
Arch Pathol Lab Med. 1992 Nov;116(11):1192-6.
10
Variable expression of leucocyte-common (CD45) antigen in CD30 (Ki1)-positive anaplastic large-cell lymphoma: implications for the differential diagnosis between lymphoid and nonlymphoid malignancies.
Hum Pathol. 1990 Jun;21(6):624-9. doi: 10.1016/s0046-8177(96)90009-x.

引用本文的文献

1
T-cell lymphomas, a challenging disease: types, treatments, and future.T细胞淋巴瘤:一种具有挑战性的疾病——类型、治疗及未来
Int J Clin Oncol. 2017 Feb;22(1):18-51. doi: 10.1007/s10147-016-1045-2. Epub 2016 Oct 14.
2
Primary platelet-derived growth factor-producing, spindle-shaped diffuse large B-cell lymphoma of the skull: a case report and literature review.原发性血小板衍生生长因子产生型颅骨梭形弥漫性大B细胞淋巴瘤:一例报告及文献复习
Int J Clin Exp Pathol. 2014 Jun 15;7(7):4381-90. eCollection 2014.
3
Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma.
半乳糖凝集素-3是一种β-半乳糖苷结合动物凝集素,是间变性大细胞淋巴瘤的标志物。
Am J Pathol. 1996 Jan;148(1):25-30.
4
Co-expression of Epstein-Barr virus latent membrane protein and vimentin in "aggressive" histological subtypes of Hodgkin's disease.爱泼斯坦-巴尔病毒潜伏膜蛋白与波形蛋白在霍奇金淋巴瘤“侵袭性”组织学亚型中的共表达
Virchows Arch A Pathol Anat Histopathol. 1993;422(1):39-45. doi: 10.1007/BF01605131.
5
Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas.石蜡切片免疫组织化学在霍奇金淋巴瘤和间变性大细胞(CD30+)淋巴瘤诊断中的应用
Virchows Arch A Pathol Anat Histopathol. 1992;420(6):527-32. doi: 10.1007/BF01600258.
6
Sialosylated Lewis chi expression in CD30-positive anaplastic large-cell lymphomas.唾液酸化路易斯χ在CD30阳性间变性大细胞淋巴瘤中的表达
J Cancer Res Clin Oncol. 1992;119(2):87-90. doi: 10.1007/BF01209661.